{{Rsnum
|rsid=7548864
|Gene=FCER1A
|Chromosome=1
|position=159297465
|Orientation=plus
|GMAF=0.2626
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FCER1A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 13.3 | 85.0
| HCB | 30.7 | 56.2 | 13.1
| JPT | 26.5 | 51.3 | 22.1
| YRI | 8.2 | 44.9 | 46.9
| ASW | 1.8 | 45.6 | 52.6
| CHB | 30.7 | 56.2 | 13.1
| CHD | 30.3 | 50.5 | 19.3
| GIH | 5.0 | 47.5 | 47.5
| LWK | 12.7 | 40.0 | 47.3
| MEX | 0.0 | 27.6 | 72.4
| MKK | 11.6 | 52.9 | 35.5
| TSI | 0.0 | 15.7 | 84.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=19372141
|Title=Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}